Evidence map›Paper›PMID 26699638›Full record

ArticleJournal of virology2015

Generation of Recombinant Oropouche Viruses Lacking the Nonstructural Protein NSm or NSs.

Natasha L Tilston-Lunel, Gustavo Olszanski Acrani, Richard E Randall, Richard M Elliott

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. A bibliometric analysis of Oropouche virus.Frontiers in microbiology · 2024
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. The global outbreak of Oropouche virus: surveillance of global trends.Tropical diseases, travel medicine and vaccines · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Multi-Epitope mRNA Vaccine TargetingBioinformatics and biology insights · 2026
    Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Natasha L Tilston-LunelMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland Biomedical Sciences Research Complex, University of St. Andrews, St. Andrews, Scotland natasha.tilston@gmail.com.ORCID http://orcid.org/0000-0002-5290-9350
Gustavo Olszanski AcraniMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland Department of Cell and Molecular Biology, University of São Paulo School of Medicine, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-5786-6732
Richard E RandallBiomedical Sciences Research Complex, University of St. Andrews, St. Andrews, Scotland.
Richard M ElliottMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland.
University of St Andrews · GBMRC University of Glasgow Centre for Virus Research · GBUniversidade de São Paulo · BR

Funding

Wellcome Trust 101792
6 · The paper itself

Abstract

unlabelledOropouche virus (OROV) is a midge-borne human pathogen with a geographic distribution in South America. OROV was first isolated in 1955, and since then, it has been known to cause recurring outbreaks of a dengue-like illness in the Amazonian regions of Brazil. OROV, however, remains one of the most poorly understood emerging viral zoonoses. Here we describe the successful recovery of infectious OROV entirely from cDNA copies of its genome and generation of OROV mutant viruses lacking either the NSm or the NSs coding region. Characterization of the recombinant viruses carried out in vitro demonstrated that the NSs protein of OROV is an interferon (IFN) antagonist as in other NSs-encoding bunyaviruses. Additionally, we demonstrate the importance of the nine C-terminal amino acids of OROV NSs in IFN antagonistic activity. OROV was also found to be sensitive to IFN-α when cells were pretreated; however, the virus was still capable of replicating at doses as high as 10,000 U/ml of IFN-α, in contrast to the family prototype BUNV. We found that OROV lacking the NSm protein displayed characteristics similar to those of the wild-type virus, suggesting that the NSm protein is dispensable for virus replication in the mammalian and mosquito cell lines that were tested. IMPORTANCE: Oropouche virus (OROV) is a public health threat in Central and South America, where it causes periodic outbreaks of dengue-like illness. In Brazil, OROV is the second most frequent cause of arboviral febrile illness after dengue virus, and with the current rates of urban expansion, more cases of this emerging viral zoonosis could occur. To better understand the molecular biology of OROV, we have successfully rescued the virus along with mutants. We have established that the C terminus of the NSs protein is important in interferon antagonism and that the NSm protein is dispensable for virus replication in cell culture. The tools described in this paper are important in terms of understanding this important yet neglected human pathogen.

Indexed as

Host-Pathogen InteractionsVirus ReplicationAnimalsCell LineHumansInterferonsOrthobunyavirusReverse GeneticsViral Nonstructural ProteinsInterferonsViral Nonstructural Proteins

Identifiers

PMID26699638
PMCPMC4810690
OpenAlexW2424076606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.